Duker Jay S.
Insider CIK 1630864 · PSDV President and COO, Director · EBIO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EYPT EyePoint, Inc. | M Exercise deriv | 2026-07-10 | 2026-07-14 | 16,667 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint, Inc. | F Tax w/h | 2026-07-10 | 2026-07-14 | 8,059 | $14.72 | $118.6K | 9,594 | SEC↗ |
| EYPT EyePoint, Inc. | M Exercise | 2026-07-10 | 2026-07-14 | 16,667 | — | $0 | 17,653 | SEC↗ |
| EYPT EyePoint, Inc. | J Other deriv | 2026-03-23 | 2026-03-24 | 52,500 | $8.75 | $459.4K | 7,800 | SEC↗ |
| EYPT EyePoint, Inc. | J Other deriv | 2026-03-23 | 2026-03-24 | 52,500 | $8.75 | $459.4K | 52,500 | SEC↗ |
| EYPT EyePoint, Inc. | J Other deriv | 2026-03-23 | 2026-03-24 | 97,500 | $9.57 | $933.1K | 82,500 | SEC↗ |
| EYPT EyePoint, Inc. | J Other deriv | 2026-03-23 | 2026-03-24 | 97,500 | $9.57 | $933.1K | 97,500 | SEC↗ |
| EYPT EyePoint, Inc. | J Other | 2026-03-23 | 2026-03-24 | 76,766 | $13.11 | $1.01M | 177,431 | SEC↗ |
| EYPT EyePoint, Inc. | J Other | 2026-03-23 | 2026-03-24 | 76,766 | $13.11 | $1.01M | 986 | SEC↗ |
| EYPT EyePoint, Inc. | P Buy | 2026-03-16 | 2026-03-16 | 1,500 | $13.15 | $19.7K | 100,665 | SEC↗ |
| EYPT EyePoint, Inc. | M Exercise deriv | 2026-01-06 | 2026-01-07 | 20,793 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint, Inc. | F Tax w/h | 2026-01-06 | 2026-01-07 | 10,054 | $16.86 | $169.5K | 77,752 | SEC↗ |
| EYPT EyePoint, Inc. | M Exercise | 2026-01-06 | 2026-01-07 | 20,793 | — | $0 | 87,806 | SEC↗ |
| EYPT EyePoint, Inc. | M Exercise deriv | 2026-01-05 | 2026-01-06 | 30,000 | — | $0 | 30,000 | SEC↗ |
| EYPT EyePoint, Inc. | F Tax w/h | 2026-01-05 | 2026-01-06 | 14,505 | $17.43 | $252.8K | 67,013 | SEC↗ |
| EYPT EyePoint, Inc. | M Exercise | 2026-01-05 | 2026-01-06 | 30,000 | — | $0 | 81,518 | SEC↗ |
| EYPT EyePoint, Inc. | M Exercise deriv | 2026-01-03 | 2026-01-06 | 65,000 | — | $0 | 130,000 | SEC↗ |
| EYPT EyePoint, Inc. | F Tax w/h | 2026-01-03 | 2026-01-06 | 23,447 | $17.48 | $409.9K | 51,518 | SEC↗ |
| EYPT EyePoint, Inc. | M Exercise | 2026-01-03 | 2026-01-06 | 65,000 | — | $0 | 74,965 | SEC↗ |
| EYPT EyePoint, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 331,000 | — | $0 | 331,000 | SEC↗ |
| EYPT EyePoint, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 165,000 | — | $0 | 165,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2025-07-10 | 2025-07-11 | 16,667 | — | $0 | 16,667 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | F Tax w/h | 2025-07-10 | 2025-07-11 | 7,688 | $11.06 | $85.0K | 9,965 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2025-07-10 | 2025-07-11 | 16,667 | — | $0 | 17,653 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | J Other | 2025-06-23 | 2025-06-25 | 56,665 | $8.21 | $465.2K | 986 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | J Other | 2025-03-19 | 2025-03-20 | 20,000 | $6.16 | $123.2K | 57,651 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2025-02-09 | 2025-02-11 | 7,000 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | F Tax w/h | 2025-02-09 | 2025-02-11 | 2,055 | $6.50 | $13.4K | 77,651 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2025-02-09 | 2025-02-11 | 7,000 | — | $0 | 79,706 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2025-01-06 | 2025-01-07 | 20,794 | — | $0 | 39,206 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2025-01-06 | 2025-01-07 | 20,794 | — | $0 | 78,814 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | F Tax w/h | 2025-01-06 | 2025-01-07 | 6,108 | $8.68 | $53.0K | 72,706 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2025-01-05 | 2025-01-07 | 30,000 | — | $0 | 60,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | F Tax w/h | 2025-01-05 | 2025-01-07 | 10,007 | $8.26 | $82.7K | 58,020 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2025-01-05 | 2025-01-07 | 30,000 | — | $0 | 68,027 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2025-01-03 | 2025-01-07 | 195,000 | — | $0 | 228,334 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2025-01-03 | 2025-01-07 | 390,000 | — | $0 | 390,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2024-07-10 | 2024-07-12 | 16,666 | — | $0 | 33,334 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | F Tax w/h | 2024-07-10 | 2024-07-12 | 8,059 | $8.69 | $70.0K | 38,027 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2024-07-10 | 2024-07-12 | 16,666 | — | $0 | 46,086 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | G Gift | 2024-02-27 | 2024-02-28 | 2,500 | — | $0 | 22,500 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | G Gift | 2024-02-27 | 2024-02-28 | 2,500 | — | $0 | 29,420 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | G Gift | 2024-02-20 | 2024-02-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | G Gift | 2024-02-20 | 2024-02-22 | 20,000 | — | $0 | 31,920 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2024-02-09 | 2024-02-13 | 4,967 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2024-02-09 | 2024-02-13 | 7,000 | — | $0 | 7,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | F Tax w/h | 2024-02-09 | 2024-02-13 | 2,075 | $28.80 | $59.8K | 53,378 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2024-02-09 | 2024-02-13 | 4,967 | — | $0 | 55,453 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2024-02-09 | 2024-02-13 | 7,000 | — | $0 | 50,486 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | F Tax w/h | 2024-02-09 | 2024-02-13 | 1,458 | $28.80 | $42.0K | 51,920 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2024-01-06 | 2024-01-09 | 20,793 | — | $0 | 41,587 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2024-01-06 | 2024-01-09 | 20,793 | — | $0 | 50,014 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | F Tax w/h | 2024-01-06 | 2024-01-09 | 6,528 | $20.40 | $133.2K | 43,486 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2024-01-05 | 2024-01-09 | 180,000 | — | $0 | 180,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2024-01-05 | 2024-01-09 | 90,000 | — | $0 | 90,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2023-07-10 | 2023-07-12 | 50,000 | — | $0 | 50,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2023-07-10 | 2023-07-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2023-06-20 | 2023-06-22 | 62,380 | — | $0 | 62,380 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2023-02-09 | 2023-02-13 | 4,967 | — | $0 | 4,967 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2023-02-09 | 2023-02-13 | 7,000 | — | $0 | 14,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2023-02-09 | 2023-02-13 | 4,967 | — | $0 | 33,369 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | F Tax w/h | 2023-02-09 | 2023-02-13 | 1,722 | $4.17 | $7.2K | 29,221 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2023-02-09 | 2023-02-13 | 7,000 | — | $0 | 28,402 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | F Tax w/h | 2023-02-09 | 2023-02-13 | 2,426 | $4.17 | $10.1K | 30,943 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2023-01-06 | 2023-01-10 | 124,755 | — | $0 | 124,755 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2022-11-01 | 2022-11-03 | 15,258 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2022-11-01 | 2022-11-03 | 15,258 | — | $0 | 25,881 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | F Tax w/h | 2022-11-01 | 2022-11-03 | 4,479 | $5.42 | $24.3K | 21,402 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2022-09-07 | 2022-09-09 | 65,300 | — | $0 | 65,300 | SEC↗ |
| SESN Sesen Bio, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 65,000 | — | $0 | 65,000 | SEC↗ |
| SESN Sesen Bio, Inc. | A Award | 2022-06-22 | 2022-06-24 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2022-02-09 | 2022-02-11 | 4,966 | — | $0 | 9,934 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2022-02-09 | 2022-02-11 | 85,000 | — | $0 | 85,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2022-02-09 | 2022-02-11 | 21,000 | — | $0 | 21,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2022-02-09 | 2022-02-11 | 4,966 | — | $0 | 10,623 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2021-11-01 | 2022-09-09 | 239,700 | — | $0 | 239,700 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2021-11-01 | 2021-11-03 | 305,000 | — | $0 | 305,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2021-11-01 | 2021-11-03 | 15,258 | — | $0 | 15,258 | SEC↗ |
| SESN Sesen Bio, Inc. | A Award deriv | 2021-05-03 | 2021-05-05 | 92,500 | — | $0 | 92,500 | SEC↗ |
| SESN Sesen Bio, Inc. | A Award deriv | 2020-05-06 | 2020-05-08 | 59,000 | — | $0 | 59,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2020-02-28 | 2020-03-03 | 33,500 | — | $0 | 33,500 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2020-02-28 | 2020-03-03 | 19,000 | — | $0 | 19,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2019-06-25 | 2019-06-27 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2019-06-21 | 2019-06-24 | 6,667 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2019-06-21 | 2019-06-24 | 6,667 | — | $0 | 44,167 | SEC↗ |
| SESN Sesen Bio, Inc. | A Award deriv | 2019-06-19 | 2019-06-21 | 52,500 | — | $0 | 52,500 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2019-04-12 | 2019-04-16 | 20,000 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2019-04-12 | 2019-04-16 | 20,000 | $1.77 | $35.4K | 37,500 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | P Buy | 2019-04-01 | 2019-04-03 | 5,000 | $1.89 | $9.4K | 17,500 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2018-06-27 | 2018-06-29 | 12,500 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2018-06-27 | 2018-06-29 | 12,500 | — | $0 | 12,500 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2018-06-21 | 2018-06-26 | 6,667 | — | $0 | 6,667 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2018-06-21 | 2018-06-26 | 26,667 | — | $0 | 26,667 | SEC↗ |
| SESN Sesen Bio, Inc. | A Award deriv | 2018-06-12 | 2018-06-14 | 52,500 | — | $0 | 52,500 | SEC↗ |
| PSDV pSivida Corp. | A Award deriv | 2017-12-15 | 2017-12-19 | 12,500 | — | $0 | 12,500 | SEC↗ |
| PSDV pSivida Corp. | A Award deriv | 2017-12-15 | 2017-12-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | A Award deriv | 2017-05-19 | 2017-05-23 | 8,072 | — | $0 | 8,072 | SEC↗ |
| PSDV pSivida Corp. | A Award deriv | 2016-12-12 | 2016-12-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | A Award deriv | 2016-06-08 | 2016-06-10 | 8,072 | — | $0 | 8,072 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | A Award deriv | 2015-01-20 | 2015-01-22 | 16,143 | — | $0 | 16,143 | SEC↗ |